Home/Filings/4/0001127602-25-005981
4//SEC Filing

MORANDI BRANDI GALVIN 4

Accession 0001127602-25-005981

CIK 0001101239other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 4:20 PM ET

Size

31.3 KB

Accession

0001127602-25-005981

Insider Transaction Report

Form 4
Period: 2025-02-18
MORANDI BRANDI GALVIN
Chief People Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-18+1,55610,235 total
  • Exercise/Conversion

    Common Stock

    2025-02-18+1,03111,266 total
  • Exercise/Conversion

    Common Stock

    2025-02-18+68711,953 total
  • Sale

    Common Stock

    2025-02-19$925.62/sh300$277,68711,653 total
  • Sale

    Common Stock

    2025-02-19$926.90/sh518$480,13411,135 total
  • Sale

    Common Stock

    2025-02-19$927.91/sh57$52,89111,078 total
  • Sale

    Common Stock

    2025-02-19$928.80/sh200$185,76110,878 total
  • Sale

    Common Stock

    2025-02-19$932.22/sh300$279,66610,578 total
  • Sale

    Common Stock

    2025-02-19$933.38/sh49$45,73510,529 total
  • Sale

    Common Stock

    2025-02-19$934.72/sh200$186,94410,329 total
  • Sale

    Common Stock

    2025-02-19$935.88/sh68$63,64010,261 total
  • Award

    Restricted Stock Unit

    2025-02-18+3,1113,111 total
    Exercise: $0.00Common Stock (3,111 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-181,5561,555 total
    Exercise: $0.00Common Stock (1,556 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-181,0310 total
    Exercise: $0.00Common Stock (1,031 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-18687687 total
    Exercise: $0.00Common Stock (687 underlying)
Footnotes (13)
  • [F1]Includes 30 shares acquired under the Equinix, Inc. Employee Stock Purchase Plan on February 14, 2025.
  • [F10]On March 7, 2024 the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2024. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2025, 25% will vest on February 15, 2026 and the remaining 25% will vest on February 15, 2027, subject solely to continued service.
  • [F11]Restricted stock unit award expires upon reporting person's termination of service.
  • [F12]On February 23, 2022, the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2022. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2023, 25% will vest on February 15, 2024 and the remaining 25% will vest on February 15, 2025, subject solely to continued service.
  • [F13]On February 14, 2023, the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2023. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 12, 2024, 25% will vest on February 15, 2025 and the remaining 25% will vest on February 15, 2026, subject solely to continued service.
  • [F2]Shares were sold pursuant to a 10b5-1 Trading Plan in order to raise funds to pay the required withholding tax pursuant to the vesting of RSUs.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $925.410 to $925.83, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4 through 9 to this Form 4.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $926.64 to $927.42 inclusive.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $927.89 to $927.92 inclusive.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $928.71 to $928.90 inclusive.
  • [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $931.76 to $932.53 inclusive.
  • [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $933.27 to $933.59 inclusive.
  • [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $935.78 to $936.18 inclusive.

Issuer

EQUINIX INC

CIK 0001101239

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001219928

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:20 PM ET
Size
31.3 KB